Educational Objectives

The PHA Preceptorship Program is designed to improve competence, performance and patient care practices by instructing front-line clinicians in the highest quality of care for patients with PAH. At the conclusion of this program, participants should be able to:

  • Define key pathophysiologic and epidemiologic components of PAH
  • Accurately diagnose patients through comprehensive screening and early recognition of symptoms
  • Evaluate the patient’s condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
  • Tailor comprehensive care for complex patient populations 

The combination of didactic discourse and highly interactive case-based discussions will provide those attending with:

  • Concise, clinically relevant information
  • New or refined skills that will improve patient care
  • Up-to-date referral resources and strengthened relationships with the nearest established PAH center
  • Better awareness of and access to clinical trials that might be of benefit to their patients.

AMA Category 1 credit is available for this activity.

 

DIAMOND
SUPPORTER

PLATINUM
SUPPORTER

GOLD
SUPPORTER

SILVER
SUPPORTER

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.

 

University of Michigan Medical School 
This activity is jointly sponsored by Washington University School of Medicine, Continuing Medical Education and the Pulmonary Hypertension Association.

PHA ONLINE UNIVERSITY

Read the Advances in PH journal, take free CME/CEU courses, access presentations from major PH conferences, locate a medical education event near you and more.

Visit PHA Online University

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

For the best viewing experience of this site, it is recommended that you use Internet Explorer 8 or 9 or Firefox.

© 2014 Pulmonary Hypertension Association. All Rights Reserved.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.®

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.